The present invention relates to the use of compounds which increase extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically to the use of 3-disubstituted phenyl-1-pyrrolidinols for the treatment of central nervous system disorders.
本发明涉及使用化合物来增加哺乳动物大脑中大脑皮层区域的
儿茶酚胺、
多巴胺和
去甲肾上腺素的细胞外
水平,更具体地,涉及使用3-二取代苯基-1-
吡咯烷醇治疗中枢神经系统疾病。